Hod Hasharon, Israel December 2023 – ATLASense Biomed, a developer of advanced medical monitoring technologies, is proud to announce that it has been awarded a significant grant from the Israel Innovation Authority. The grant will fund a development project for an innovative and unique technology to predict respiratory deterioration in patients with respiratory conditions, particularly those with COPD and CHF, SF, and in respiratory rehabilitation.
This new technology is based on the REPHAEL platform, a system for continuous remote patient monitoring, and the PolyMonitor, a non-invasive wearable multi-sensor device that monitors a wide range of physiological parameters.
The uniqueness of this technology lies in its ability to collect multiple physiological data simultaneously and continuously, incorporating unique sensors developed by ATLASense Biomed. These sensors, a product of the accumulated and unique knowledge of the company’s scientific team, enable accurate and reliable monitoring of vital signs, detection of abnormal patterns, and prediction of respiratory deterioration at an early stage.
“We are immensely proud to announce that ATLASense Biomed has been awarded a second prestigious grant from the Israeli Innovation Authority, recognizing our ongoing commitment to innovation in healthcare. This grant supports the development of our groundbreaking predictive analytics application focused on early detection and prevention of respiratory deterioration.
Earning the Israeli Innovation Authority’s recognition for the second time highlights our team’s dedication to transforming patient care through advanced, life-saving technology. By combining real-time monitoring with predictive insights, our goal is to empower healthcare providers to intervene earlier, prevent crises, and ultimately improve patient outcomes. This support fuels our mission to redefine remote patient monitoring, and we are honored to continue pioneering solutions that make a meaningful difference in healthcare.
Thanks the Israeli Innovation Authority for this validation of our vision. We look forward to achieving new milestones together on our journey to a healthier, safer future.”
This development is expected to significantly contribute to improving the care of patients with COPD and CHF, reducing hospitalization rates, and enhancing their quality of life.
About ATLASense Biomed:
ATLASense Biomed is an Israeli company developing innovative medical monitoring technologies. The company’s REPHAEL system provides continuous remote patient monitoring, enabling early detection of deterioration in patients’ condition.
About the Israel Innovation Authority:
The Israel Innovation Authority is a governmental agency tasked with promoting technological innovation in Israel. The Authority supports startups and mature technology companies and encourages the development of innovative technologies in various fields.